# Caribou Biosciences, Inc.: Form SCHEDULE 13D, filed Apr 25, 2025

- Company: [Caribou Biosciences, Inc.](/companies/crbu.md) (CIK 1619856)
- Form: SCHEDULE 13D
- Filed: 2025-04-25
- Accepted by EDGAR: Apr 25, 2025, 16:40 ET
- Period: not reported
- Accession: 0000950170-25-058810
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1619856/000095017025058810/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1619856/000095017025058810/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1619856/000095017025058810/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Apr 25, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-058810. Last ingested by Listed: Nov 5, 2026, 17:23 ET. No prices; not investment advice.